Orsini Selected by Sarepta Therapeutics to Dispense ELEVIDYS (delandistrogene moxeparvovec-rokl), the First Gene Therapy to Treat Duchenne Muscular Dystrophy

ELK GROVE VILLAGE, III., June 27, 2023 /PRNewswire/ — Orsini Specialty Pharmacy, a leading independent specialty pharmacy focused on rare diseases and gene therapies, announced today that Sarepta Therapeutics, Inc. has selected the company as one of its limited distribution providers of…